Introduction

Structural Characterization of Emerging Synthetic Drugs by Mass Spectrometry

Structural Characterization of Emerging Synthetic Drugs by Mass Spectrometry

This webinar originally occurred on March 5, 2021
Duration: 1 hour

Overview

The main focus of this webinar is on the use of isotope labeling, multi-stage mass spectrometry (MSn), ion spectroscopy, and accurate mass measurements with high resolution mass spectrometry to demonstrate some important—but previously unidentified—rearrangement mechanisms in the spectra of cathinones and fentanyl analogs. Although many of these techniques are not available to practitioners, the results provide compelling evidence to support the fragmentation mechanisms and pathways observed every day by practitioners.

We demonstrate two important intermediates in the fragmentation spectra of cathinones like alpha-PVP, both of which are based on a phthalane core. These intermediates are important in understanding the mass spectra of a wide variety of cathinones. We also demonstrate common pathways for the fragmentation of fentanyl analogs and evidence for at least three different structures for the major fragmentation product at m/z 188 in the tandem mass spectra or protonated fentanyl analogs.

Finally, we present a novel algorithm for the comparison of mass spectra, which takes advantage of the fact that the variance in ion abundances of replicate spectra are not independently variable, as has long been assumed. The algorithm uses a general linear regression model (GLM) to predict the ion abundances of each of the 15 most abundant ions in a mass spectrum of a questioned sample. A binary classifier then uses the correctness of the predicted ion abundances to decide whether or not to identity the questioned sample as a particular drug. Using external validation spectra of hundreds of replicate spectra, the algorithm predicts abundances with a precision that is typically five times better than models that assume a fixed exemplar.

Detailed Learning Objectives

  1. Major fragmentation pathways of protonated cathinones
  2. Major fragmentation pathways of protonated fentanyl analogs
  3. Mathematical comparison of fragment ion abundances for drug identifications

Presenter

  • Glen P. Jackson, Ph.D., FRSC, FAAFS

Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

White Paper – Forensic Community Drug Database Conceptualization

Date February 2024 Overview The National Institute of Justice (NIJ)-in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)-convened a virtual Medicolegal Death…

Technical Note – The Use of Neutral Losses and Common Fragments Screening by QTOF in Forensic Laboratories

Date February 2024 Overview Quadrupole time-of-flight (QTOF) mass spectrometry is an advanced analytical technique that has some capabilities that make it particularly useful in screening in toxicology cases for unknown analytes. The technology combines the power of a quadrupole mass…

Drug Surveillance Initiatives: An FTCOE Repository of Resources

Date December 2023 Overview In the realm of drug surveillance, a multitude of data sources originate from diverse funding agencies, including but not limited to the Drug Enforcement Administration (DEA), National Institute on Drug Abuse (NIDA), Centers for Disease Control…